Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selectis HealthGBCS +0.66%43 Debt-to-Equity is 66.68 as of Mar. 2026, which is 474% above its 10-year median of 11.62. GuruFocus rates GBCS with a GF Score™ of 43/100 and a GF Value™ of $2.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 557 Healthcare Providers & Services companies, Selectis Health ranks worse than 100% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Selectis Health's Debt-to-Equity or its related term are showing as below:
GBCS'
s Debt-to-Equity Range Over the Past 10 Years
Min: -12.57 Med: 11.62 Max: 66.68
Current: 66.68
During the past 13 years, the highest Debt-to-Equity Ratio of Selectis Health was 66.68. The lowest was -12.57. And the median was 11.62.
GBCS's Debt-to-Equity is ranked worse than 100% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs GBCS: 66.68
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Selectis Health Debt-to-Equity Related Terms
Selectis Health Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Selectis Health's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GBCS vs ADIA, CCM, CDIX: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Selectis Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Selectis Health's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a Debt-to-Equity of 66.68 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Selectis Health and its competitors. This is 474% above median its historical median of 11.62. According to the industry distribution chart, Selectis Health ranks #557 out of 557 companies in the Healthcare Providers & Services industry.
Is Selectis Health's Debt-to-Equity too high?
Selectis Health's current Debt-to-Equity of 66.68 is 474% above median its 10-year median of 11.62. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Selectis Health's value of 66.68 is 15776.2% above this industry median. Based on the distribution chart, Selectis Health ranks #557 out of 557 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Selectis Health has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Debt-to-Equity compare to ADIA and CCM?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #557 out of 557 companies for Debt-to-Equity. This places Selectis Health in the lower half of its industry. The industry median Debt-to-Equity is 0.42. Selectis Health's value of 66.68 is 15776.2% above this benchmark. While the company's 10-year median is 11.62 vs. the industry median of 0.42, Selectis Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selectis Health's current Debt-to-Equity of 66.68 is 15776.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current Debt-to-Equity is 66.68, which is 474% above median its own 10-year median of 11.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.15, compared to a current price of $5.65 — trading 162.8% above its estimated fair value. The current Debt-to-Equity is 66.68, which is 474% above median its 10-year median of 11.62 and 15776.2% above the Healthcare Providers & Services industry median of 0.42. Selectis Health's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Selectis Health (GBCS), the current Debt-to-Equity is 66.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.65 is trading 162.8% above its estimated GF Value™ of $2.15.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
Debt-to-Equity: 66.68 (474% above median its 10-year median of 11.62)
GF Value™: $2.15 vs. price of $5.65 (162.8% above fair value)
Industry Position: 15776.2% above the Healthcare Providers & Services median (#557 of 557)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
43GF Score
Get the complete analysis for GBCS
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
